Chapter 20
Thrombolytic Therapy for Peripheral Arterial and Venous Thrombosis
W. Todd Bohannon,
Michael B. Silver Jr.,
W. Todd Bohannon
Search for more papers by this authorMichael B. Silver Jr.
Search for more papers by this authorW. Todd Bohannon,
Michael B. Silver Jr.,
W. Todd Bohannon
Search for more papers by this authorMichael B. Silver Jr.
Search for more papers by this authorBook Editor(s):Enrico Ascher,
L. H. Hollier,
D. Eugene Strandness,
Jonathan B. Towne,
Keith Calligaro,
K. Craig Kent,
Gregory L. Moneta,
William H. Pearce,
John J. Ricotta,
Henry Haimovici,
Enrico Ascher
Search for more papers by this authorL. H. Hollier
Search for more papers by this authorD. Eugene Strandness
Search for more papers by this authorJonathan B. Towne
Search for more papers by this authorKeith Calligaro
Search for more papers by this authorK. Craig Kent
Search for more papers by this authorGregory L. Moneta
Search for more papers by this authorWilliam H. Pearce
Search for more papers by this authorJohn J. Ricotta
Search for more papers by this authorHenry Haimovici
Search for more papers by this authorFirst published: 01 January 2004
Summary
This chapter contains section titled:
-
Arterial Thrombolysis
-
Venous Thrombolysis
-
Conclusion
References
- Flier JS, Underhill LH. Molecular and cellular biology of blood coagulation. N Engl J Med 1992; 326: 800–806.
- Chang R, Powell RJ, Sumpio BE. Tissue plasminogen activator-biologic perspectives for surgeons. J Am Coll Surg 1997; 184: 529–39.
- Blinc A, Francis CW. Transport processes in fibrinolysis and fibrinolytic therapy. Thromb Haemost 1996; 76: 481–91.
- Alkjaersig N, Fletcher AP, Sherry S. The mechanism of clot dissolution by plasmin. J Clin Invest 1959; 38: 1086–95.
- Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988 Aug 13; 2 (8607): 349–60.
- Keyt BA, Paoni NF, et al. A faster-acting and more potent form of tissue plasminogen activator. Proc Natl Acad Sci 1994, 91: 3670–4.
- Meierhenrich R, Carlsson J, et al. Effect of reteplase on hemostasis variables: analysis of fibrin specificity, relation to bleeding complications and coronary patency. Int J Cardiol 1998, 65: 57–63.
- Ouriel K, Shortell CK, et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 1994, 19: 1021–30.
- Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE Trial. Ann Surg 1994; 220: 251–68.
- Ouriel K, Veith FJ, Sasahara AA. A comparison of re-combinate urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 1998; 338: 1105–11.
- Thrombolysis in the management of lower limb peripheral arterial occlusion: a consensus document. Working party on thrombolysis in the management of limb ischemia. Am J Cardiol 1998; 81: 207–18.
- Coulon M, Goffette P, Dondelinger RF. Local thrombolytic infusion in arterial ischemia of the upper limb: midterm results. Cardiovasc Intervent Radiol 1994; 17 (2): 81–6.
- Widlus DM, Venbrux AC, et al. Fibrinolytic therapy for upper-extremity arterial occlusions. Radiology 1990; 175 (2): 393–9.
- Cejna M, Salomonowitz E, et al. rt-PA thrombolysis in acute thromboembolic upper-extremity arterial occlusion. Cardiovasc Intervent Radiol 2001 Jul-Aug; 24 (4): 218–23.
- Sylvester PA, Davies AH, et al. The role of thrombolysis in the management of thromboembolic disorders: a four-year review. Eur J Vasc Endovasc Surg 1995; 9 (4): 459–62.
- Ouriel K, Kandarpa K, et al. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: The PURPOSE Trial. JVIR 1999; 10: 1083–91.
- Matas Docampo M, Gomez Palones F, et al. Intraarterial urokinase for acute native arterial occlusion of the limbs. Ann Vasc Surg 1997; 11 (6): 565–72.
- Swischuk JL, Fox PF, et al. Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications. J Vasc Interv Radiol 2001; 12 (4): 423–30.
- Schilling JD, Pond GD, et al. Catheter-directed urokinase thrombolysis: an adjunct to PTA/surgery for management of lower extremity thromboembolic disease. Angiology 1994: 45; 851–866.
- Steinmetz E, Bouchot O, et al. Preoperative intraarterial thrombolysis before surgical revascularization for popliteal artery aneurysm with acute ischemia. Ann Vasc Surg 2000; 14 (4): 360–4.
- Hoelting T, Paetz B, et al. The value of preoperative lytic therapy in limb-threatening acute ischemia femoropopliteal artery aneurysm. Am J Surg 1994; 168 (3): 227–31.
- Greenberg R, Wellander E, et al. Aggressive treatment of acute limb ischemia due to thrombosed popliteal aneurysms. Eur J Radiol 1998; 28 (3): 211–8.
- Garramone RR Jr, Gallagher JJ Jr, Drezner AD. Intraarterial thrombolytic therapy in the initial management of thrombosed popliteal artery aneurysms. Ann Vasc Surg. 1994; 8 (4): 363–6.
- Marty B, Wicky S, et al. Success of thrombolysis as a predictor of outcome in acute thrombosis of popliteal aneurysms. J Vasc Surg 2002 Mar; 35 (3): 487–93.
- Nackman GB, Walsh DB, et al. Thrombolysis of occluded infrainguinal vein grafts: Predictors of outcome. J Vasc Surgery 1997; 25: 1023–32.
- Graor RA, Risius B, et al. Thrombolysis of peripheral arterial bypass grafts: Surgical thrombecomy compared with thrombolysis. J Vasc Surg 1988; 7: 347–55.
- Flinn WR, McCarthy WJ, et al. Thrombolytic therapy in the management of chronic arterial occlusions. In: Comerota AJ (ed). Thrombolytic therapy for peripheral vascular disease. Lippincott Co., Philadelphia, PA, 1995: 269–277.
- Ouriel K, Shortell CK, et al. Acute peripheral arterial occlusion: Predictors of success in catheter-directed thrombolytic therapy. Radiology 1994; 193: 561–6.
- Sullivan KL, Gardiner GA, et al. Acceleration of thrombolysis with a high-dose transthrombus bolus technique. Radiology 1989; 173: 805–808.
- Braithwaite BD, Buckenham TM, et al. A prospective randomized trial of high dose verses low dose tissue plasminogen activator infusion in the management of acute limb ischemia. Br J Surg 1997; 84: 646–650.
- Glickerman DJ, Kowdley KV, Rosch J. Urokinase in gastrointestinal tract bleeding. Radiology 1988; 168 (2): 375–6.
- Malden ES, Hicks ME, et al. Recurrent gastrointestinal bleeding: use of thrombolysis with anticoagulation in diagnosis. Radiology 1998; 207 (1): 147–51.
- Bloomfeld RS, Smith TP, et al. Provocative angiography in patients with gastrointestinal hemorrhage of obscure origin. Am J Gastroenterol 2000; 95 (10): 2807–12.
- Ryan JM, Key SM, et al. Nonlocalized lower gastrointestinal bleeding: provocative bleeding studies with intraarterial tPA, heparin, and tolazoline. J Vasc Interv Radiol 2001; 12 (11): 1273–7.
- Strandness DE Jr. Thrombus propagation and level of anticoagulation. J Vasc Surg 1990; 12 (4): 497–8.
- Caps MT, Meissner MH, et al. Venous thrombus stability during acute phase of therapy. Vasc Med 1999; 4 (1): 9–14.
- Meissner MH, Manzo RA, et al. Deep venous insufficiency: The relationship between lysis and subsequent reflux. J Vasc Surg 1993; 18: 596–608.
- Arnesen H, Hoiseth A, Ly B. Streptokinase or heparin in the treatment of deep venous thrombosis: followup results of a prospective study. Acta Med Scand 1982; 211: 65–71.
- Jeffery P, Immelman E, Ammore J. Treatment of deep venous thrombosis with heparin or streptokinase: long- term versus function assessment. Proceedings of the Second International Vascular Symposium, London, 1986.
- Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: a clinical review. Can J Surg 1993; 36 (4): 359–64.
- Johnson BF, Manzo RA, et al. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: A one- to six-year followup. J Vasc Surg 1995; 21: 307–13.
- Camerota AJ, Throm RC, et al. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000; 32: 130–7.
- Semba CP, Dake MD. Iliofemoral deep venous thrombosis: Aggressive therapy with catheter-directed thrombolysis. Radiology 1994; 191: 487–94.
- Comerota AJ, Aldridge SC, et al. A strategy of aggressive regional therapy for acute iliofemoral venous thrombosis with contemporary venous thrombectomy or catheter-directed thrombolysis. J Vasc Surg 1994; 20 (2): 244–54.
- Bjarnason H, Kruse JR, et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol 1997; 8 (3): 405–18.
- Mewissen MW, Seabrook GR, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: Report of a national multicenter registry. Radiology 1999; 211: 39–49.
- Hingorani A, Ascher E, et al. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg 1997; 26: 853–60.
- Kerr TM, Lutter KS, et al. Upper extremity venous thrombosis diagnosed by duplex scanning. Am J Surg 1990; 160: 202–206.
- Prandoni P, Bernardi E. Upper-extremity deep vein thrombosis. Current opinions in pulmonary medicine 1999; 5: 222–226.
- Carman TL, Fernandez BB. Issues and controversies in venous thromboembolism. Cleve Clin J Med 1999; 66: 113–23.
- Horattas MC, Wright DJ, et al. Changing concepts of deep venous thrombosis of the upper extremity: report of a series and review of the literature. Surgery 1988; 104: 561–7.
- Hingorani A, Ascher E, et al. Upper extremity verses lower extremity deep venous thrombosis. Am J Surg 1997; 174: 214–217.
- Prandoni P, Polistena P, et al. Upper-extremity deep vein thrombosis: risk factors, diagnosis, and complications. Arch Intern Med 1997; 157: 57–62.
- Chang R, Horne MK, et al. Pulse-spray treatment of subclavian and jugular venous thrombi with recombinant tissue plasminogen activator. JVIR 1996; 7: 845–851.
- Morasch MD, Ebaugh JL, et al. Mesenteric venous thrombosis: a changing clinical entity. J Vasc Surg 2001; 34 (4): 680–4.
- Rhee RY, Gloviczki P, et al. Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg 1994; 20 (5): 688–97.
- Rhee RY, Gloviczki P. Mesenteric venous thrombosis. Surg Clin North Am 1997; 77 (2): 327–38.
- Hassan HA, Raufman JP. Mesenteric venous thrombosis. South Med J 1999; 92 (6): 558–62.
- Brunaud L, Antunes L, et al. Acute mesenteric venous thrombosis: case for nonoperative management. J Vasc Surg 2001; 34 (4): 673–9.
- Schafer C, Zundler J, Bode JC. Thrombolytic therapy in patients with portal vein thrombosis: case report and review of the literature. Eur J Gastroenterol Hepatol 2000; 12 (10): 1141–5.
- Suzuki S, Nakamura S, et al. Portal vein thrombosis after splenectomy successfully treated by an enormous dosage of fibrinolytic agent in a short period: report of two cases. Surg Today 1992; 22 (5): 464–9.
- Guckelberger O, Bechstein WO, et al. Successful recanalization of late portal vein thrombosis after liver transplantation using systemic low-dose recombinant tissue plasminogen activator. Transpl Int 1999; 12 (4): 273–7.
- Yankes JR, Uglietta JP, et al. Percutaneous transhepatic recanalization and thrombolysis of the superior mesenteric vein. Am J Roentgenol 1988; 151 289–90.
- Bilbao JI, Rodriguez-Cabello J, et al. Portal thrombosis: percutaneous transhepatic treatment with urokinase: a case report. Gastrointest Radiol 1989; 14 (4): 326–8.
- Bizollon T, Bissuel F, et al. Fibrinolytic therapy for portal vein thrombosis. Lancet 1991; 337 (8754): 1416.
- Rivitz SM, Geller SC, et al. Treatment of acute mesenteric venous thrombosis with transjugular intramesenteric urokinase infusion. J Vasc Interv Radiol 1995; 6 (2): 219–23.
- Sehgal M, Haskal ZJ. Use of transjugular intrahepatic portosystemic shunts during lytic therapy of extensive portal splenic and mesenteric venous thrombosis: long-term followup. J Vasc Interv Radiol 2000; 11 (1): 61–5.
- Aytekin C, Boyvat F, et al. Catheter-directed thrombolysis with transjugular access in portal vein thrombosis secondary to pancreatitis. Eur J Radiol 2001; 39 (2): 80–2.
- Poplausky MR, Kaufman JA, et al. Mesenteric venous thrombosis treated with urokinase via the superior mesenteric artery. Gastroenterology 1996; 110 (5): 1633–5.
- Train JS, Ross H, et al. Mesenteric venous thrombosis: successful treatment by intraarterial lytic therapy. J Vasc Interv Radiol 1998; 9 (3): 461–4.
- Ludwig DJ, Hauptmann E, et al. Mesenteric and portal vein thrombosis in a young patient with protein S deficiency treated with urokinase via the superior mesenteric artery. J Vasc Surg 1999; 30 (3): 551–4.
- Rundback JH. Mesenteric venous thrombosis: successful treatment by intraarterial lytic therapy. J Vasc Interv Radiol 1999; 10 (1): 98–9.
- Antoch G, Taleb N, et al. Transarterial thrombolysis of portal and mesenteric vein thrombosis: a promising alternative to common therapy. Eur J Vasc Endovasc Surg 2001; 21 (5): 471–2.
- Sze DY, O'Sullivan GJ, et al. Mesenteric and portal venous thrombosis treated by transjugular mechanical thrombolysis. Am J Roentgenol 2000; 175 (3): 732–4.
